NCT07209111
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07209111
Title A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) (KANDLELIT-014)
Acronym KANDLELIT-014
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | SWE | POL | NOR | ITA | ISR | GRC | ESP | DNK | DEU | AUS


No variant requirements are available.